Showing results (51-60 of 60) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 60 results.
Trials|April 12, 2024
Supported exercise TrAining for Men wIth prostate caNcer on Androgen deprivation therapy (STAMINA): study protocol for a randomised controlled trial of the clinical and cost-effectiveness of the STAMINA lifestyle intervention compared with optimised usual care, including internal pilot and parallel process evaluationEmma McNaught, Sophie Reale, Liam Bourke, et al.
European Journal of Cancer (Oxford, England : 1990)|September 15, 2012
Superiority of denosumab to zoledronic acid for prevention of skeletal-related events: a combined analysis of 3 pivotal, randomised, phase 3 trialsAllan Lipton, Karim Fizazi, Alison T Stopeck, et al.
Journal for Immunotherapy of Cancer|July 26, 2024
Targeting a STING agonist to perivascular macrophages in prostate tumors delays resistance to androgen deprivation therapyHaider Al-Janabi, Katy Moyes, Richard Allen, et al.
The Journal of Pathology|November 15, 2018
Identification and validation of DOCK4 as a potential biomarker for risk of bone metastasis development in patients with early breast cancerJules A Westbrook, Steven L Wood, David A Cairns, et al.
Cancer Research|August 2, 2018
Modulating Bone Marrow Hematopoietic Lineage Potential to Prevent Bone Metastasis in Breast CancerJessalyn M Ubellacker, Ninib Baryawno, Nicolas Severe, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 9, 2016
Randomized Open-Label Phase II Trial of Apitolisib (GDC-0980), a Novel Inhibitor of the PI3K/Mammalian Target of Rapamycin Pathway, Versus Everolimus in Patients With Metastatic Renal Cell CarcinomaThomas Powles, Mark R Lackner, Stéphane Oudard, et al.
BJU International|June 4, 2016
Cost-effectiveness of zoledronic acid and strontium-89 as bone protecting treatments in addition to chemotherapy in patients with metastatic castrate-refractory prostate cancer: results from the TRAPEZE trial (ISRCTN 12808747)Lazaros Andronis, Ilias Goranitis, Sarah Pirrie, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 24, 2019
Endogenous Production of IL1B by Breast Cancer Cells Drives Metastasis and Colonization of the Bone MicroenvironmentClaudia Tulotta, Diane V Lefley, Katy Freeman, et al.
Molecular Cancer Therapeutics|December 10, 2020
Macrophages Mediate the Antitumor Effects of the Oncolytic Virus HSV1716 in Mammary TumorsAmy Kwan, Natalie Winder, Emer Atkinson, et al.
The Lancet. Oncology|February 16, 2023
Temporary treatment cessation versus continuation of first-line tyrosine kinase inhibitor in patients with advanced clear cell renal cell carcinoma (STAR): an open-label, non-inferiority, randomised, controlled, phase 2/3 trialJanet E Brown, Kara-Louise Royle, Walter Gregory, et al.
Pageof 6